Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Bioclinical Group — Predicate Candidate Screening

9 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

33 daysmedian FDA review time
64 days90th percentile
9clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K862968FREE T3 RADIOIMMUNOASSAY KITBioclinical Group1986-09-25500
K853837LH/FSH RADIOIMMUNOASSAY KITBioclinical Group1985-10-16300
K832638CORTISOL RADIOIMMUNOASSAY KITBioclinical Group1983-09-12390
K823005BIO MAG FREE T4 RADIOIMMUNOASSAY KITBioclinical Group1982-12-15640
K823004BIO MAG TOTAL T4 RADIOIMMUNOASSAY KITBioclinical Group1982-11-05240
K822840RADIOIMMUNOASSAY, HUMAN CHORRIONICBioclinical Group1982-10-27340
K822515B-HCG RADIOIMMUNOASSAY KITBioclinical Group1982-09-14250
K821241FREE T4 RADIOIMMUNOASSAY KITBioclinical Group1982-06-01330
K821101TOTAL RADIOIMMUNOASSAY KITBioclinical Group1982-05-05150

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda